Loading clinical trials...
Loading clinical trials...
Effect of Remimazolam Total Intravenous Anesthesia-flumazenil Antagonism Guided by Different Target Range for the Bispectral Index in Short-duration Ear Nose Throat Surgeries: A Retrospective Cohort Study
Conditions
Start Date
February 1, 2026
Primary Completion Date
February 28, 2026
Completion Date
March 31, 2026
Last Updated
March 3, 2026
NCT07454629
NCT07050212
NCT07046364
NCT06716840
NCT05891145
NCT06685770
Lead Sponsor
Tongji Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions